Tech Company Financing Transactions
Numerate Funding Round
Numerate secured a $4 million Series A funding round on 11/18/2008. Investors included Foundation Capital, Lanza techVentures and private investors.
Transaction Overview
Company Name
Announced On
11/18/2008
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Series A
Investors
Foundation Capital (Adam Grosser)
Proceeds Purpose
This investment will help Numerate to pursue a broad range of partnering opportunities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1501 Mariposa St. 426
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Website
Email Address
Overview
Numerate engineers rather than discovers drugs. We have built and validated our Drug Engineering Process to deliver leads faster, cheaper and more predictably.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Guido Lanza
Chief Scientific Officer
John Griffin
Chief Technical Officer
Brandon Allgood
Vice President
Uwe Klein
Browse more venture capital transactions:
Prev: 11/17/2008: Eureka Therapeutics venture capital transaction
Next: 11/18/2008: ReGen Power Systems venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs